PI3K/Akt-mediated PDGFRalpha signaling in craniofacial development
颅面发育中 PI3K/Akt 介导的 PDGFRalpha 信号传导
基本信息
- 批准号:8316882
- 负责人:
- 金额:$ 5.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-30 至 2014-09-29
- 项目状态:已结题
- 来源:
- 关键词:AdultAntibodiesBiochemicalBiological AssayBiologyBromodeoxyuridineCell ProliferationCell physiologyCellsChemicalsCleft PalateComplexCongenital AbnormalityDefectDevelopmentDiseaseEmbryoFaceGene TargetingGeneticGenetic EpistasisGrowthGrowth FactorHumanIn VitroIncidenceKnowledgeLaboratoriesLifeLigandsLive BirthMass Spectrum AnalysisMediatingMesenchymeMetabolismMolecularMusMutant Strains MiceMutationPDGFRB genePalatePathway interactionsPhenotypePhosphorylationPlasmidsPlatelet-Derived Growth FactorPlayPreventionProcessProteinsProteomicsRNA InterferenceReagentResearchRoleSignal PathwaySignal TransductionSmall Interfering RNATransfectionVascular DiseasesWestern BlottingWorkcell growthcleft lip and palatecraniofacialhuman diseasein vitro activityin vivoinhibitor/antagonistinnovationinsightmigrationmouse modelmutantmutant mouse modelnovelnovel therapeuticsoverexpressionprotein expressionresearch studytumor
项目摘要
DESCRIPTION (provided by applicant): Craniofacial development is a complex morphogenic process, disruptions in which result in highly prevalent birth defects in humans. Platelet-derived growth factor (PDGF) signaling plays a critical role in craniofacial development, as evidenced by the phenotypes of mouse models with mutations in the pathway, which range from a cleft palate to shortening of the frontonasal masses and complete facial clefting. While PDGF signaling has been extensively analyzed from a biochemical perspective at the cellular and molecular level, the role of this growth factor signaling pathway and its downstream effectors in craniofacial development have just begun to be explored. Previous work by the Soriano laboratory has identified PI3K as the main downstream effector of PDGFR¿ signaling during craniofacial development in the mouse, however, further downstream pathways are currently unknown. Because PI3K/Akt signaling impacts signaling pathways that have such disparate functions in proliferation, cell growth or metabolism, it is critical to build on the present knowledge and defie the intracellular signaling pathways regulated by PDGFR¿ in defining craniofacial development in vivo. These studies will provide a more complete understanding of the mechanisms of PDGF signaling in midline development and its disruption in human disease. The aim of this proposal is to identify and characterize the intracellular pathways downstream of PI3K-mediated PDGFR¿ signaling in craniofacial development. We will combine state-of-the art proteomic approaches with in vitro cell activity assays and in vivo genetic interaction studies to characterize the role of Akt phosphorylation targets during midline development. First, protein phosphorylation downstream of Akt will be examined in primary mouse embryonic palatal mesenchyme (MEPM) cells under various PDGFR¿ signaling contexts by Western blot analysis and differentially phosphorylated proteins will be identified by mass spectrometry. Secondly, the effect of Akt phosphorylation target misexpression on MEPM cell proliferation, growth and migration will be analyzed in vitro via transfection of expression plasmids or siRNA duplexes. Finally, the role of Akt phosphorylation targets in craniofacial development will be characterized in vivo through genetic epistasis experiments between PDGFR¿ and target gene mutant mice. The innovative studies proposed here will provide critical insight into the role of PDGF signaling in vivo, by characterizing the intracellular pathways downstream of PI3K-mediated PDGFR¿ signaling in midline development. Our research strategy will take advantage of the vast array of reagents available for this growth factor signaling pathway to explore novel aspects of craniofacial biology and ultimately, provide new therapeutic directions aimed at the prevention of craniofacial birth defects.
PUBLIC HEALTH RELEVANCE: Platelet-derived growth factor (PDGF) signaling has been shown to regulate numerous processes throughout the body, both during development and adult life, and aberrant PDGF signaling has been implicated in defects in craniofacial development, tumors, vascular disorders and fibrotic diseases. Defects in craniofacial development, including cleft lip and palate (CL/P), comprise the most prevalent birth defects in humans, with an estimated incidence of 1/500 to 1/2,000 live births. The PDGF signaling studies proposed here will impart valuable insight into the intracellular pathways and molecular mechanisms contributing to craniofacial development, and ultimately, provide new therapeutic directions aimed at the prevention of craniofacial birth defects.
描述(由申请人提供):颅面发育是一个复杂的形态发生过程,其中断导致人类出生缺陷非常普遍。血小板源性生长因子(PDGF)信号传导在颅面发育中起着关键作用,这一点可以通过该途径突变的小鼠模型的表型来证明,其范围从腭裂到额鼻肿块缩短和完全的面部裂开。虽然PDGF信号已经从细胞和分子水平的生物化学角度进行了广泛的分析,但这种生长因子信号通路及其下游效应物在颅面发育中的作用才刚刚开始探索。Soriano实验室以前的工作已经确定PI 3 K是小鼠颅面发育过程中PDGFR信号传导的主要下游效应子,然而,进一步的下游途径目前尚不清楚。由于PI 3 K/Akt信号传导影响在增殖、细胞生长或代谢中具有如此不同功能的信号传导途径,因此建立在现有知识的基础上并在定义体内颅面发育中定义由PDGFR调节的细胞内信号传导途径是至关重要的。这些研究将提供一个更完整的了解PDGF信号传导的机制,在中线的发展和它的中断在人类疾病。该提案的目的是确定和表征颅面发育中PI 3 K介导的PDGFR信号传导下游的细胞内途径。我们将联合收割机最先进的蛋白质组学方法与体外细胞活性测定和体内遗传相互作用研究相结合,以表征Akt磷酸化靶点在中线发育过程中的作用。首先,通过蛋白质印迹分析在各种PDGFR信号传导背景下在原代小鼠胚胎腭间充质(MEPM)细胞中检查Akt下游的蛋白质磷酸化,并通过质谱鉴定差异磷酸化的蛋白质。其次,通过转染表达质粒或siRNA双链体,体外分析Akt磷酸化靶点错误表达对MEPM细胞增殖、生长和迁移的影响。最后,Akt磷酸化靶点在颅面发育中的作用将通过PDGFR和靶基因突变小鼠之间的遗传上位性实验在体内进行表征。本文提出的创新研究将通过表征中线发育中PI 3 K介导的PDGFRs信号传导下游的细胞内途径,为体内PDGF信号传导的作用提供重要见解。我们的研究策略将利用可用于这种生长因子信号通路的大量试剂来探索颅面生物学的新方面,并最终提供旨在预防颅面出生缺陷的新治疗方向。
公共卫生相关性:血小板衍生生长因子(PDGF)信号传导已被证明在发育和成年期间调节整个身体的许多过程,并且异常的PDGF信号传导已涉及颅面发育、肿瘤、血管病症和纤维化疾病中的缺陷。颅面发育缺陷,包括唇腭裂(CL/P),是人类最常见的出生缺陷,估计发病率为1/500至1/2,000活产。本文提出的PDGF信号转导研究将为颅面发育的细胞内途径和分子机制提供有价值的见解,并最终为预防颅面出生缺陷提供新的治疗方向。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Ann Fantauzzo其他文献
Katherine Ann Fantauzzo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Ann Fantauzzo', 18)}}的其他基金
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10650417 - 财政年份:2022
- 资助金额:
$ 5.3万 - 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
- 批准号:
10518288 - 财政年份:2022
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
10361222 - 财政年份:2019
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
10576282 - 财政年份:2019
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
10326848 - 财政年份:2018
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
10545287 - 财政年份:2018
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
10358047 - 财政年份:2018
- 资助金额:
$ 5.3万 - 项目类别:
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme
颅面间质中 PDGFR 二聚体特异性动力学的表征
- 批准号:
9499789 - 财政年份:2018
- 资助金额:
$ 5.3万 - 项目类别:
PDGFRbeta signaling in craniofacial development.
颅面发育中的 PDGFRbeta 信号传导。
- 批准号:
9091493 - 财政年份:2015
- 资助金额:
$ 5.3万 - 项目类别:
PI3K/Akt-mediated PDGFRalpha signaling in craniofacial development
颅面发育中 PI3K/Akt 介导的 PDGFRalpha 信号传导
- 批准号:
8540149 - 财政年份:2012
- 资助金额:
$ 5.3万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别: